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The performance of a hollow-fiber membrane bioreactor (HFBR) (molecular weight 
cut-off 30 kD, fiber surface area 2050 cm2) containing a culture of hybridoma cells has 
been investigated. Experimental data were used as basis to develop a model of general 
application. Concentrations of fundamental nutrients (glucose and glutamine), inhibitory 
products (ammonium and lactate), and monoclonal antibodies (MAb) against bovine lac-
toferrin (IgG1) were monitored over time. Exchange of nutrients and products occurred 
across the capillary surface, whereas cells and MAb remained in the extra-capillary space 
(ECS). A protein-free culture medium (Hybrimax) with and without antibiotics was used. 
In both cases, the final MAb concentration was the same; however, antibiotic presence 
slowed down the time to achieve this concentration. Diffusion assays have been carried 
out in order to support the development of a mathematical model that describes the per-
formance of the HFBR, including mass transfer and reaction terms. Inhibition by ammo-
nium and lactate has been considered in the kinetics, providing model results consistent 
with experimental data. Further research with other cell lines and/or culture media will 
allow to broaden the field of application of this model for general use in HFBR systems.
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Introduction
Hybridoma technology was developed to over-
come the limitations of polyclonal antibodies (broad 
specificity, possible cross-reactivity or variability 
among immune serum batches)1. Monoclonal anti-
bodies (MAb) are currently used in many applica-
tions, such as the diagnosis and treatment of certain 
diseases and the purification of substances. The 
growing demand for monoclonal antibodies at rea-
sonable prices means that it is necessary to carry 
out an optimization of their production processes2.
Since the development of cell hybridoma tech-
nology, production of ascites in mice has been the 
primary method available for the production of 
large amounts of monoclonal antibodies3. However, 
as in vivo assays are controversial and criticized for 
both practical and ethical reasons, manufacturers 
and Official Medicines Control Laboratories are en-
couraged to develop and implement alternative 
methods to limit the use of such methods4. Thus, in 
the last decade, researchers have developed numer-
ous in vitro methodologies for hybridoma culture. 
The development of these assays offers the benefit 
of replacing mice ascites, enabling the production 
of large amounts of monoclonal antibodies under 
well-controlled conditions5.
Analysis of the evolution of substrate and prod-
uct concentrations is fundamental in the determina-
tion of hybridoma kinetics. Glucose and glutamine 
are key substrates for hybridoma growth. Glucose is 
mainly transformed into pyruvate, while pyruvate is 
partially converted to lactic acid. Part of the gluta-
mine is deaminated, yielding ammonium and gluta-
mate, which is later transformed into other amino 
acids for biosynthesis purposes. Whereas glucose 
and glutamine are fundamental nutrients, ammoni-
um and lactate are products of cell metabolism that 
can act as inhibitors when their concentrations are 
high enough6. Regarding the culture medium, the 
use of a protein-free medium facilitates subsequent 
purification of the monoclonal antibodies. Addition-
ally, due to increasing safety concerns as well as 
cost issues, the requirements for biotechnological 
*Corresponding author: mariodiaz@uniovi.es; 
Phone: (+34) 985 10 34 39 Fax: (+34) 985 10 34 34
doi: 10.15255/CABEQ.2015.2207
Original scientific paper 
Received: April 1, 2015 
Accepted: May 31, 2016
L. Legazpi et al., Diffusion and Inhibition Processes in a Hollow-fiber Membrane…
213–225
214 L. Legazpi et al., Diffusion and Inhibition Processes in a Hollow-fiber Membrane…, Chem. Biochem. Eng. Q., 30 (2) 213–225 (2016)
processes now include the use of media free from 
animal-derived components7.
As regards in vitro techniques, hybridoma cul-
ture has been traditionally carried out in bags, 
flasks, or bottles. However, cell densities and MAb 
concentrations obtained in batch culture are gener-
ally low8. This disadvantage is overcome by the use 
of hollow-fiber membrane-based bioreactors 
(HFBR), which allow higher antibody concentra-
tions and relatively lower operating costs. For these 
reasons, the use of hollow-fiber cell culture technol-
ogy has greatly expanded worldwide9,10.
Hollow-fiber modules provide a high surface to 
volume ratio, as much as 200 cm2 per mL. This al-
lows a large number of cells to aggregate in a very 
small volume, thus obtaining high cell densities. 
Jain and Kumar11 have reported cells yields up to 
107–109. These authors have also stated that HFBR 
systems are well suited for the production of anti-
bodies in semi-continuous operation in concentra-
tions higher than 2 mg mL–1 day, using a protein-free 
medium. The main disadvantage of using a hol-
low-fiber bioreactor for an extended period is that 
the system is prone to be contaminated during the 
replacement of the culture medium and recovery. 
Antibiotics are usually added to in vitro cell cul-
tures to avoid this problem12,13. It is essential to 
know how antibiotics affect MAb production, how-
ever there are limited works focused on this sub-
ject14,15,16, and the operative mechanisms of antibiot-
ics with cell metabolism are still not clear17,18. One 
example of the existing works is the study devel-
oped by Barnabé and Butler14 who reported that 
MAb specific production rates were not affected 
by low concentrations of tunicamycin (0.01–0.1 
μg mL–1), whereas higher antibiotic concentrations 
(1 μg mL–1) made cell viability decrease and speci-
fic production rates increase, probably due to pas-
sive antibody release by non-viable cells.
Furthermore, the production of monoclonal an-
tibodies by means of hybridoma cell lines has be-
come an important biotechnological task. The effi-
ciency of these processes can be further enhanced 
by developing macroscopic models, which can con-
stitute valuable tools to reduce time and costs of 
bioprocess development19. The goal in modelling 
complex systems, such as MAb production by hy-
bridoma cells, is the development of simple models 
that estimate system performance with an accept-
able level of accuracy.
Thus, antibodies are well established in main-
stream clinical practice as well as in research ar-
eas20. Additionally, in recent years, hollow-fiber 
membrane-based bioreactors have been reported as 
apt cell culture systems for therapeutic applica-
tions9, such as tissue engineering21 or growing red 
blood cells22. Therefore, in this paper, the perfor-
mance of hybridoma cells in a HFBR system was 
analyzed as a case study of cell culture in a mem-
brane reactor. Modelling is increasingly being used 
to understand bioreactor behaviour, specifically 
some attempts to model hybridoma growth23,24 and 
MAb production25,26 in HFBR have been carried 
out. Moreover, different authors have recently pro-
posed sophisticated mathematical equations to de-
scribe hybridoma metabolism and antibody produc-
tion in batch cultures19,20. However, as far as we 
know, there are virtually no published studies that 
consider both hybridoma metabolism and MAb pro-
duction in HFBR systems. This paper has devel-
oped an easily applicable reaction-diffusion model, 
assuming certain simplifications based on addition-
al experiments, to assess the performance of the 
system, i.e. conversion of substrates (glucose and 
glutamine) into products (lactate and ammonium), 
as well as MAb production with and without antibi-
otics. Hence, the aim of this work was to contribute 
to the understanding of hybridoma culture perfor-
mance in HFBR systems and, at the same time, de-
velop a model of general application for cultures 
carried out in similar membrane bioreactors.
Materials and methods
Cell line and cell culture
The hybridoma cell line studied here was HB-
8852 (American Type Culture Collection) that pro-
duces IgG1 monoclonal antibodies against bovine 
lactoferrin. A protein-free culture medium (Hybri-
max) was employed.
The cell culture was developed following the 
procedure described by Legazpi et al.6 Hybridoma 
cells were cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM) supplemented with 20 % (v/v) 
fetal bovine serum (FBS), and subsequently a grad-
ual adaptation to DMEM with 10 % (v/v) FBS was 
carried out. The cells were then passed to Hybrimax 
with 10 % (v/v) FBS and adapted so as to grow in 
Hybrimax with 4 % (v/v) FBS. A buffer of MOPS 
(3-(N-morpholino)propanesulfonic acid) and bicar-
bonate were employed to maintain the pH of the 
culture medium close to 7.2. This adaptation pro-
cess was carried out in T-flasks and, once adapted 
to grow in Hybrimax with 4 % (v/v) FBS, 3.4 · 107 
viable cells were inoculated into the HFBR ex-
tra-capillary space (ECS 12 mL volume). The cells 
were then gradually adapted to Hybrimax without 
serum in four steps (3 %, 2 %, 1 %, and 0 % (v/v) 
FBS). This process lasted approximately 5 weeks. 
All the reagents were supplied by Sigma-Aldrich.
The HFBR (CELLMAX) (Thermo Fisher Sci-
entific Inc., Waltham, USA) consisted of a bundle 
of 2565 cellulose fibers with a molecular weight 
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cut-off value of 30 kD, and a length of 13 cm. The 
fiber wall thickness was 15 μm, the internal diame-
ter 180 μm, and the external diameter 210 μm. The 
medium was contained in a reservoir (a 500-mL 
bottle containing 300 mL of medium), and circulat-
ed within the capillaries while the cells were grown 
in the ECS. Exchange of nutrients and products oc-
curred across the capillary surface, whereas cells 
and MAb remained in the ECS (IgG size 150–170 
kD). The pumping medium was continually oxy-
genated, since passive gas exchange was realized 
by a silicone tubing device connected to the HFBR 
system. The flow was approximately 17 mL min–1. 
The operation was semi-continuous, the HFBR 
worked in a closed-circuit system, although the ex-
hausted medium was regularly replaced by fresh 
Hybrimax (when the lactate concentration reached 
1000–1200 ppm) (Fig. 1).
The cells were cultured in an incubator main-
tained at 37 ºC with 5 % CO
2
 in air. The experi-
ments were performed with and without antibiotics 
(SIGMA Penicillin-Streptomycin Solution with 
10000 units penicillin and 10 mg mL–1 streptomy-
cin; 1:50 dilution) (Sigma-Aldrich Corp., St. Louis, 
USA). When the experiment with antibiotics was 
completed, the medium was replaced by fresh Hy-
brimax and, after a lapse of 24 hours, the experi-
ment without antibiotics commenced. As explained 
model development section, the cell growth during 
the experiment was quite low and the order of 
 magnitude in the concentration of cells was main-
tained.
Analysis
Samples of 4 mL of medium were taken with a 
syringe from the bottle, filtered through 0.45 µm 
pore membranes, divided into aliquots, and frozen 
at –20 ºC for later analysis. This sampling size was 
chosen so that the change in the medium volume 
(~12 %) did not affect kinetic results. Glucose con-
centration was determined by the dinitrosalicylic 
acid method (S.D. < 3 mM). Glutamine concentra-
tion was determined using an enzymatic kit (SIG-
MA, Ref.: GLN-2) (S.D. < 0.1 mM). Lactate was 
determined by ion exchange chromatography (Ion-
Pac AS4A-SC column, IonPac AG4A-SC guard 
column) (S.D. < 0.3 mM). Ammonium concentra-
tion was determined by ion exchange chromatogra-
phy (IonPac CS-10 column, IonPac CG10 guard 
column) (S.D. < 0.1 mM). To quantify antibody 
IgG1, 120 μL samples were taken through the ports 
with a syringe from the bundle and analyzed using 
an enzyme-linked immunosorbent assay (ELISA) 
(S.D. < 3 µg mL–1). Ion exchange chromatography 
columns were supplied by Thermo Fisher Scientific 
Inc. and reagents by Sigma-Aldrich. These analysis 
methods are detailed in Legazpi et al.6
At the end of the culture, all cells were harvest-
ed with a syringe through the sample ports of the 
cartridge. Dry weight was employed to quantify the 
final concentration of cells in the ECS.
Statistical analyses
In order to evaluate the effect of antibiotics on 
HFBR performance, experimental data for sub-
strates (glucose and glutamine) and products (lac-
tate and ammonium) were analysed by running con-
trast of hypothesis tests at a 95.0 % confidence 
level. “The antibiotics do not affect the bioreactor 
performance” is the null hypothesis (H0), whereas 
the alternative hypothesis (H1) is “the antibiotics af-
fect the bioreactor performance”. Kolmogorov- 
-Smir nov and Shapiro-Wilk tests were used to as-
sess that all the samples came from normal distribu-
tions. These analyses were performed using IBM 
SPSS Statistics 20 (International Business Machines 
Corp., New York, USA).
Diffusion assays
Nutrients passed through the wall of the fibers 
from the capillaries to the ECS where hybridoma 
cells were immobilized, whereas products diffused 
from the extra-capillary space inside the lumen fi-
bers. With the aim of determining the hydrodynam-
ic parameters needed to model the system, diffusion 
assays were performed with the main compounds 
involved in the process (glucose, glutamine, lactate, 
and ammonium) without cells.
F i g .  1  – Schematic representation of the HFBR system
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For the analysis of glucose diffusion, the car-
tridge was loaded with distilled water and the medi-
um bottle was filled with a solution of glucose at a 
concentration similar to those employed in the ex-
periments with hybridoma cells (initial concentra-
tion 4.0 mg mL–1). Samples were then taken regu-
larly from the ECS to evaluate the rate of diffusion 
of glucose from the capillaries. Glutamine diffusion 
was assessed in the same manner (initial concentra-
tion 0.34 mg mL–1).
For the products (lactate and ammonium), the 
medium bottle was filled with distilled water, and 
the cartridge was loaded with a solution of lactate 
or ammonium in a concentration similar to those ob-
 tained in the experiments with hybridoma cells (ini-
tial concentrations 1.0 mg mL–1 and 0.046 mg mL–1, 
respectively). Samples were also taken from the 
ECS.
Model development
Calculation of mass transfer coefficients
Diffusion assays allowed the estimation of the 
mass transfer coefficient values (K´L) required to 
solve the model equations. In the absence of cells, 
the material that appears/disappears in the ECS is 
equal to the material that passes through the fiber 
walls.






e L,GLC i,GLC e,GLC
C
V = K´ A C C
t
−






e L,GLN i,GLN e,GLN
C
V = K´ A C C
t
−
where Ve is the volume of the ECS, K´L the mass 
transfer coefficient for glucose (GLC) or glutamine 
(GLN), A the total fiber surface area, Ci the sub-
strate concentration in the intra-capillary space 
(equal to the concentration in the bottle), and Ce 
the substrate concentration in the extra-capillary 
space.
The ECS volume was 12 mL and the total fiber 
surface area was 2050 cm2. As no reaction is taking 
place, Ci can be expressed as a function of Ce:
   (3) 
 
( )i,GLC initial i e,GLC e
i,GLC
i




   (4) 
 
( )i,GLN initial i e,GLN e
i,GLN
i




where Vi is the volume of medium in the bottle.
Substituting Equations (3) and (4) in Equations 
(1) and (2) and integrating, we obtain:
 
 
where (Ci)initial and (Ce)initial are the substrate concen-
trations of glucose (GLC) or glutamine (GLN) at the 
beginning of the diffusion experiments, and t the 
experiment time. Plotting HGLC or HGLN vs. t, a line 
is obtained for each substrate, and the correspond-
ing mass transfer coefficient can be calculated from 
the slope of this line. The mass transfer coefficients 
of products were calculated in a similar way.
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Assumptions of the model
Seeing as the goal was to develop an easily ap-
plicable model for a complex system, a number of 
significant simplifications were introduced. Several 
initial assumptions normally considered by different 
researchers were assumed: isothermal process; 
Newtonian uncompressible fluid with constant 
physical properties; flow rates and pressures being 
uniformly distributed over the module cross-sec-
tion; fiber bundles being regarded as a collection of 
parallel rods, which means that the packing-density 
distribution and flow distribution were consistent 
along the module length; the fibers had the same 
diameter, were rigid and could not be deformed; 
and entrance and exit effects in the lumen as well as 
the end effects in the shell were ignored28.
Other approximations and simplifications are 
listed and justified below:
1) In the HFBR, the inflow concentration of 
any compound (Ci, inlet) was approximately the same 
as the outflow concentration (Ci, outlet).
Assuming perfect mixing in the bottle and not 
taking into account the time that the medium takes 
to circulate from the HFBR to the bottle, the amount 
of substance that appears/disappears in the bottle 
during an increment of time is the same as the 
amount of substance that disappears/appears in the 
bundle of fibers:
 ( )i inlet i, outlet i, inletV C = Q C C t∆ − ∆   (7)
where Q is the flow through the ICS, Vi
 the volume 
of medium in the bottle, and t the time.
If the difference between Cinlet and Coutlet is a 
percentage of Cinlet, α, it can be written as:
 ( )i, outlet i, inlet i, inletC C = Cα−   (8)
From Equation (1) and being τ = Vi /Q:



















As Q = 1020 mL h–1 and Vi
 = 300 mL, then τ = 
0.29 h. The values obtained for α will be comment-
ed in Results and discussion and this assumption 
will be justified.
2) The time that the medium takes to circulate 
from the bottle to the HFBR and from the HFBR to 
the bottle was negligible in the context of the exper-
iment. It is known that the medium took 2.3 min to 
reach the cartridge from the bottle, whereas the 
products took 0.9 min to get from the cartridge to 
the bottle. This time (3.2 min in all) is insignificant 
with respect to the rate of change of the concentra-
tions in the studied compounds. It is important to 
remark that, taking into account the experimental 
data (shown in Results and discussion section), the 
variation of substrates and products concentrations 
during these 3.2 min was always below 5 %.
3) The cell growth that took place during the 
experiments was negligible with respect to the high 
cell concentrations in the cartridge.
The final cell biomass was determined at the 
end of the experiment, being 16 mg mL–1 dry weight 
(~5·107 cell mL–1). The initial concentration was 
calculated considering the kinetic values for hybrid-
oma growth in a T-flask6 and assuming similar be-
havior, obtained was a value of the same order of 
magnitude, only 20 % lower than the final concen-
tration.
4) The volume of culture medium contained in 
the bottle was virtually constant throughout the ex-
periments. The initial volume was 300 mL. As 9 
samples of 4 mL were taken, the final volume was 
264 mL, just 12 % lower.
Model equations
Considering the assumptions postulated in the 
previous section, simple equations can be estab-
lished to describe the system behavior based on 
mass balance in the bottle and in the intra-capillary 
space for substrates as well as products.
It was considered that the void spaces among 
cell layers around neighboring hollow fiber mem-
branes give negligible contribution to flow in the 
ECS. Likewise, the flow resistance and the possible 
change in membrane properties caused by the adhe-
sion of cells to the fiber membranes were also sup-
posed negligible9,28.
The material that disappears/appears in the bot-
tle is equal to the material that passes through the 
fiber walls:






i L,GLC i,GLC e,GLC
C
V = K´ A C C
t
− −






i L,GLN i,GLN e,GLN
C
V = K´ A C C
t
− −






i L, LAC e, LAC i, LAC
C
V = K´ A C C
t
−






i L, AM e, AM i, AM
C
V = K´ A C C
t
−
where Vi is the volume of medium in the bottle, K´L 
the mass transfer coefficients for glucose (GLC), 
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glutamine (GLN), lactate (LAC) or ammonium 
(AM), Ci the concentration in the intra-capillary 
space (equal to the concentration in the bottle), Ce 
the concentration in the extra-capillary space, and A 
the fiber surface area.
The material that appears/disappears in the ex-
tra-capillary space is equal to the material that pass-
es through the fiber walls minus/plus the consump-
tion/production by the hybridoma cells:
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V = K´ A C C +V r
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where Ve is the volume of the extra-capillary space, 
rGLC and rGLN the rates of consumption of glucose 
and glutamine, and rLAC and rAM the rates of forma-
tion of lactate and ammonium, respectively.
The rates of substrate consumption and product 
generation were considered proportional to the via-
ble cell concentrations. In addition, two inhibitory 
terms for lactate and ammonium were introduced in 
order to take into account the reduction in consump-
tion and production rates observed during the final 
hours of the experiment. Equations 15–18 can be 
rewritten as follows:
where q and p are the maximum specific rates for 
substrates glucose (GLC) or glutamine (GLN) and 
products lactate (LAC) or ammonium (AM), Xv the 
cell concentration, (Ce, LAC )
* and (Ce, AM )
* the maxi-
mum concentrations of lactate and ammonium that 
can be obtained (extrapolated from experimental 
data), and nLAC and nAM the exponents of the inhibi-
tory terms.
It has been reported that byproducts such as 
ammonium and lactate affect cell physiology and 
metabolism.29 For instance, Schneider et al.30 re-
ported inhibition of glutamine uptake by elevated 
ammonia concentrations. Besides, it is a well-
known fact that accumulation of these cellular me-
tabolism byproducts may inhibit hybridoma MAb 
production.11,29
The produced antibody remained in the ex-
tra-capillary space; so, in this case, only the produc-
tion term is necessary. Two inhibitory terms were 
once again considered:
 





e, MAb e, LAC e, AM
MAb v




   
   − −
   
   
where Ce, MAb is the antibody concentration in the ex-
tra-capillary space, pMAb the maximum specific pro-
duction rate for antibody, and n´LAC and n´AM the ex-
ponents of the inhibitory terms.
L. Legazpi et al., Diffusion and Inhibition Processes in a Hollow-fiber Membrane…, Chem. Biochem. Eng. Q., 30 (2) 213–225 (2016) 219
Results and discussion
Hollow-fiber bioreactor performance
Cell metabolism and antibody production
Fig. 2 shows the evolution of glucose and glu-
tamine concentrations, while Fig. 3 shows the evo-
lution of lactate and ammonium concentrations. 
Glucose and glutamine concentrations decreased 
throughout the duration of the experiment, although 
the consumption rate was slower during the last 
hours of experimentation. In a previous study car-
ried out with the same cell line in T150-flasks con-
taining 100 mL of protein-free medium6, it was ob-
served that these substrates decreased only during 
the exponential growth phase. At the end of the ex-
periment, the concentration of cells measured in the 
cartridge was 5·107 cell mL–1, approximately a quar-
ter of the concentration reported for the Alps 25-3 
hybridoma cell line in the extra-capillary space of a 
dual hollow-fiber bioreactor29. Lactate and ammoni-
um likewise increased throughout the experiment, 
as their production is associated with glucose and 
glutamine consumption. In contrast, antibody con-
centration was almost constant after 4 hours of cul-
ture in the medium without antibiotics (see Fig. 4). 
It has been previously observed that MAb produc-
tion for this cell line is not totally associated with 
cell growth6. Cell growth and antibody generation 
are conditioned by the availability of amino acids in 
the medium31. For example, the presence of gluta-
mine is a necessary condition for MAb production. 
Although, in this case, glutamine was available in 
the medium even during the final stages of the ex-
periment, it is possible that other essential amino 
acids may have been depleted. Another possibility 
is that lactate and/or ammonium inhibit antibody 
production. In fact, a considerable amount of litera-
ture exists on the inhibitory or toxic effects result-
ing from lactate and ammonia accumulation in 
mammalian cell cultures31. Specifically, an inhibito-
ry effect on cell growth and antibody production 
has been reported for these metabolic by-prod-
ucts11,19,29.
The final antibody concentration was 0.22 mg 
mL–1 (approximately 4.4 pg cell–1). This value was 
similar to that reported by Kurkela et al.32 in one day 
for a HFBR system (0.3 mg mL–1), and lower than 
that obtained by Kessler et al.33 in one day for 6C10 
cell line culture in a Tricentric bioreactor (1.8 mg 
mL–1). Street et al.34 reported a maximum antibody 
concentration of 2.4 mg mL–1 for the CB. Hep-1 hy-
F i g .  2  – Evolution of substrate concentrations (samples taken from the bottle). Experimental data with (□) and without (∆) antibi-
otics, and the results of modelling with (continuous line) and without (discontinuous line) antibiotics (eq. 11 to 14, and 19 to 22).
F i g .  3  – Evolution of product concentrations (samples taken from the bottle). Experimental data with (□) and without (∆) antibiotics 
and, the results of modelling with (continuous line) and without (discontinuous line) antibiotics (eq. 11 to 14, and 19 to 22).
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bridoma cell line in a HFBR employing protein-free 
culture medium, whereas other authors obtained 
concentrations for the same cell line that did not ex-
ceed 0.015 mg mL–1. In a recent study employing 
5A8 hybridoma cells immobilized in calcium algi-
nate, the maximum concentration obtained was 
0.006 µg mL–1 35. It is thus essential to note that anti-
body production strongly depends on the character-
istics of the medium and the cell line employed, as 
well as on the culture technique developed.
Comparison of cell metabolism and antibody 
production with and without antibiotics
The evolution of substrates (glucose and gluta-
mine) and inhibitors (lactate and ammonium) with 
and without antibiotics can be seen in Figs. 2 and 3. 
In both cases, the glucose-lactate yield was 1.0, this 
yield is approximately half the value obtained in 
T-flask culture6. These results are similar to those 
reported by other authors with a different cell line 
(AB2-143.2) in a continuous reactor36. As regards 
glutamine consumption and ammonium production 
rates, once again, these were almost the same with 
and without antibiotics, with yields of 1.2 in both 
cases. This value is approximately double the gluta-
mine-ammonium yield obtained in T-flask culture6. 
Schmid et al.37 reported similar values for the AB2-
143.2 cell line in small-scale cultures. Statistical 
tests confirmed that consumption of substrates and 
production of products were not affected signifi-
cantly by the presence of antibiotics.
Fig. 4 shows the evolution of antibody concen-
tration with and without antibiotics. Although the 
final concentration obtained was the same in both 
cases, the presence of antibiotics increased the time 
needed to reach this concentration. Whereas 4 h 
was sufficient time to obtain the maximum antibody 
concentration, approximately double this time was 
required when using antibiotics (8 h). The average 
productivity decreased from 0.002 mg mL–1 h–1 to 
0.001 mg mL–1 h–1. However, it should be noted that 
the use of antibiotics avoids system contamination 
and ensures the possibility of reusing hybridoma 
cells in several cycles with fresh medium. Accord-
ing to Da Silva17, almost all antibiotics interfere in a 
lesser or greater extent with the production of anti-
bodies as they form complexes with the DNA mol-
ecules, impeding the formation of antibodies. More 
recently, Kallala et al.18 suggested that antibiotics 
exert direct effects on mitochondrial physiology 
within mammalian cells, disrupting mitochondrial 
function and cell activity. The effect of antibiotics 
on MAb production is determined by different fac-
tors, such as antibiotic nature and concentration, 
cell lines, culture medium…14,15,16
Comparison of HFBR performance with other  
in vitro hybridoma culture techniques
Table 1 shows the comparison of MAb produc-
tion data obtained in the HFBR with data obtained 
for the same cell line and culture medium employ-
ing other in vitro hybridoma culture techniques, i.e., 
i-MAb bags and T-flasks. The use of a HFBR en-
abled much higher MAb concentrations to be ob-
tained, as was also reported by other authors11,18: 
approximately 7 times higher than that achieved 
with T-flask culture, and 3 times higher than that 
achieved with i-MAb bags. This high MAb concen-
tration facilitates the subsequent concentration and 
purification steps. Moreover, the time needed to ob-
tain the maximum MAb concentration was much 
shorter using a HFBR than with the other in vitro 
techniques. Consequently, the productivity of the 
HFBR was much higher than when employing 
the other two techniques, with a value (0.0021 
mg mL–1 h–1), the same order of magnitude as that 
reported in other hybridoma cell lines cultured in 
HFBR29. Despite these advantages, it should be not-
















(MAb obtained /culture 
medium consumed)  
(mg mL–1)
0.074 0.030 0.009
**Authors´ own data, in part reported by Legazpi et al.6
**Calculated considering the volume of culture medium 
consumed
F i g .  4  – Evolution of antibody concentration (samples taken 
from the bundle). Experimental data with (□) and without (∆) 
antibiotics and, the results of modelling with (continuous line) 
and without (discontinuous line) antibiotics (eq. 11 to 14, and 
19 to 23).
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ed that the medium yield (MAb produced in rela-
tion to consumed medium) was more than 3-fold 
higher in T-flask culture than in the HFBR, and 
8-fold higher in the case of i-MAb bags. The draw-
back of i-MAb bags is obviously the time needed to 
obtain the maximum concentration of antibodies 
(approximately one month).
The medium yield data reported in Table 1 
were calculated considering the production process 
to begin with fresh medium and end when the max-
imum MAb concentration is obtained. The actual 
operation with T-flasks and a HFBR differs slightly, 
as MAb is periodically harvested by replacing the 
used medium with fresh medium. The amount of 
MAb harvested in one month was calculated assum-
ing that 40 % of the medium contained in the T-flask 
was replaced daily with fresh medium, and that all 
the medium in the HFBR was replaced every 12 
hours. MAb production would be 37 mg per i-MAb 
bag (500 mL capacity), 12 mg per T150-flask, and 
96 mg for the HFBR. Therefore, if high amounts of 
antibody were required, it would be recommendable 
to employ an HFBR instead of other culture tech-
niques. This culture system not only enables higher 
MAb production, but also allows working for several 
months, obtaining a much more concentrated product.
Experimental system analysis  
and assessment of the model
Fig. 5 shows the evolution of substrates and 
products during the diffusion assays described in 
Materials and methods. As can be seen, it took 
30–40 min for the glucose, glutamine, lactate, and 
ammonium concentrations to be equal in the bottle 
and in the ECS. These results allowed the estima-
tion of the mass transfer coefficient values (ex-
plained in model development section) shown in 
Table 2. The validity of this estimation can be tested 
by comparing the good agreement between experi-
mental and model data (Fig. 5).
From the experimental data obtained in the dif-
fusion assays, α values were calculated in each 
sampling time for lactate, ammonium, glucose, and 
glutamine. Ninety-four percent of the obtained val-
ues for α were lower than 0.06. This means that the 
difference between the inflow and the outflow con-
centrations was less than 6 % practically throughout 
the experiments. This justified the approximation 1 
commented in model development section.
The data used to solve the model can be seen in 
Table 3. In order to calculate the qGLC, qGLN, pAM, and 
pLAC values, the specific rates of consumption and 
production obtained in the T-flask experiments were 
F i g .  5  – Evolution of substrate and product concentrations in diffusion assays (samples taken from the bundle). Experimental data 




















Ta b l e  2  – Mass transfer coefficients calculated from experi-
mental data
r2 KLi´A (mL h
–1) KLi´ (cm h
–1)
Glucose 0.959 41.0 2.0·10–2
Glutamine 0.992 67.7 3.3·10–2
Lactate 0.996 87.3 3.8·10–2
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assumed as the starting point6. A good fit was ob-
tained for glucose employing the T-flask value (qGLC 
= 0.3 h–1). For lactate and ammonium, the values of 
maximum specific production rate obtained in the 
HFBR were very similar to the specific rates of pro-
duction measured in T-flask (pLAC = 0.25 and pAM = 
0.005 h–1, respectively). However, the maximum 
specific consumption rate of glutamine in the HFBR 
was half the specific consumption rate value ob-
tained in T-flasks (qGLN = 0.03 and qGLN = 0.06 h
–1, 
respectively). Comparing the results with and with-
out antibiotics in the HFBR, again it can be con-
cluded that the presence of antibiotics in the medi-
um had no significant effect on the reaction rates of 
substrates and products. Changes in hybridoma me-
tabolism determined by culture conditions may be 
responsible for the differences observed for gluta-
mine consumption. Cell confinement makes hybrid-
omas grow, forming biofilms and conglomerates. 
This different environment interacts with cell devel-
opment, altering morphology and membrane per-
meability, as well as surface tension and osmotic 
pressure31,35,39. Maximum specific rates found in this 
work were slightly higher than lactate and ammoni-
um specific production rates and glucose specific 
consumption rate reported by Ozturk and Palsson40 
(0.13, 0.002, and 0.14 h–1, respectively). On the 
contrary, the maximum specific consumption rates 
for glutamine were very similar (≈ 0.03 h–1). Addi-
tionally, Amribt et al.12 reported values for the max-
imum specific uptake rate for glutamine of the same 
order of magnitude.
As explained in model development section, 
inhibition by lactate and ammonium was included 
in the kinetic equations (see eq. 19–22). The expo-
nents of the inhibitory terms were assumed to be the 
same for glucose/glutamine consumption and lac-
tate/ammonium production, both values being found 
to be quite similar (nLAC = 0.10 and nAM = 0.15, re-
spectively).
As shown in Figs. 2 and 3, the agreement be-
tween experimental and model data for substrates 
and products is quite good, despite the fact that the 
model overestimates actual values in the case of the 
lactate after 8 hours.
Fig. 4 shows the evolution of antibody concen-
tration (experimental data and model results) with 
and without antibiotics. The value obtained for pMAb 
was higher without antibiotics, indicating that the 
presence of antibiotics negatively affects the pro-
duction of MAb. In both cases, the production rate 
of MAb slowed down after approximately 3 hours. 
This behavior, also observed in T-flasks6, might be 
explained by the inhibition of antibody production 
due to the accumulation of toxic byproducts, such 
as lactate and ammonia11. For these reasons, inhibi-
tory terms were also considered for MAb produc-
tion. In this case, inhibition by lactate was found to 
be stronger than inhibition by ammonium, with ex-
ponents of n´LAC = 1.3 and n´AM = 0.5, respectively. 
Model and experimental data have been compared 
with good agreement (r2 > 0.98 in all cases).
Conclusions
The use of antibiotics (streptomycin/penicillin) 
did not affect glucose and glutamine consumption 
or lactate and ammonium production. Although the 
same final concentration of antibody was obtained 
Ta b l e  3  – Parameter values, with and without antibiotics, used to solve the model
Initial  
concentrations  





























4.3 (without ant.) 
4.6 (with ant.)
4.3 (without ant.) 
4.6 (with ant.)
2.0·10–2 2050 300/12 16 0.30 1.45 0.047 0.10 0.15
Glutamine
0.38 (without ant.) 
0.34 (with ant.)
0.38 (without ant.) 
0.34 (with ant.)
3.3·10–2 2050 300/12 16 0.03 1.45 0.047 0.10 0.15
Lactate
0.14 (without ant.) 
0.11 (with ant.)
0.14 (without ant.) 
0.11 (with ant.)





1.45 0.047 0.10 0.15
Ammonium
0.013 (without ant.) 
0.016 (with ant.)
0.013 (without ant.) 
0.016 (with ant.)
3.7·10–2 2050 300/12 16 0.005 1.45 0.047 0.10 0.15
Antibody –
0.008 (without ant.) 
0.005 (with ant.)





1.45 0.047 1.30 0.50
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with and without antibiotics, twice the time was 
needed to obtain the maximum MAb concentration 
when antibiotics were added.
When antibody production in a HFBR was 
compared with other systems, i.e. T-flasks and 
i-MAb bags, the highest antibody concentration was 
obtained using a HFBR, and the time needed to ob-
tain this concentration was the shortest. However, 
the waste of medium per mg of MAb obtained was 
maximal in this case.
It was possible to simulate the system employ-
ing a simplified model that considered reaction and 
mass transfer terms. Inhibition by lactate and am-
monium was considered in the model for substrate 
consumption and product generation. The model 
accurately described the evolution of substrates and 
products, and even antibody production, which was 
found to be inhibited by ammonium and especially 
by lactate that had accumulated in the medium.
L i s t  o f  s y m b o l s  a n d  a c r o n y m s
A  – total fiber area, cm2
AM  – ammonium
Ce – concentration in cartridge ECS, mg mL
–1
(Ce)initial – initial concentration in cartridge ECS, 
mg mL–1
Ce,AM – ammonium concentration in the ECS, 
mg mL–1
Ce,GLC – glucose concentration in the ECS, mg mL
–1
Ce,GLN – glutamine concentration in the ECS, 
mg mL–1
Ce,LAC – lactate concentration in the ECS, mg mL
–1
Ce,MAb – antibody concentration in the ECS, mg mL
–1
(Ce,LAC)
* – maximum lactate concentration, mg mL–1
(Ce,AM)
* – maximum ammonium concentration, 
mg mL–1
Ci – concentration in the bottle or ICS, mg mL
–1
(Ci)initial – initial concentration in the bottle or ICS, 
mg mL–1
Ci, inlet – bundle inflow concentration, mg mL
–1
Ci, outlet – bundle outflow concentration, mg mL
–1
Ci,AM – ammonium concentration in the ICS, mg mL
–1
Ci,GLC – glucose concentration in the ICS, mg mL
–1
Ci,GLN – glutamine concentration in the ICS, mg mL
–1
Ci,LAC – lactate concentration in the ICS, mg mL
–1
ECS  – extra-capillary space
GLC  – glucose
GLN – glutamine
HFBR – hollow fiber bioreactor
ICS – intra-capillary space
K´L, AM  – mass transfer coefficient for ammonium, 
cm h–1
K´L, GLC  – mass transfer coefficient for glucose, cm h
–1
K´L, GLN  – mass transfer coefficient for glutamine, 
cm h–1
K´L, LAC  – mass transfer coefficient for lactate, cm h
–1
LAC  – lactate
MAb  – monoclonal antibody
pAM  – maximum specific production rate for am-
monium, h–1
pLAC  – maximum specific production rate for lac-
tate, h–1
qGLC  – maximum specific consumption rate for glu-
cose, h–1
qGLN  – maximum specific consumption rate for glu-
tamine, h–1
qMAb  – maximum specific production rate for anti-
body, h–1
Q  – flow, mL h–1
nAM  – exponent for inhibitory term due to ammoni-
um in eq. 19–20
nLAC  – exponent for inhibitory term due to lactate in 
eq. 19–20
n´AM  – exponent for inhibitory term due to ammoni-
um in eq. 23
n´LAC  – exponent for inhibitory term due to lactate in 
eq. 23
rAM  – ammonium production rates, mg mL
–1
rGLC  – glucose consumption rates, mg mL
–1
rGLN  – glutamine consumption rates, mg mL
–1
rLAC  – lactate production rates, mg mL
–1
SD  – standard deviation
t  – time, h
Ve  – cartridge extra-capillary volume, mL
Vi  – volume of medium in the bottle, mL
Xv  – cell concentration, cell mL
–1
τ  – retention time in the bottle, h
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